Florida State researchers discovered that gut bacteria, like Klebsiella pneumoniae, may reach the brain and…
Browsing: Alzheimer’s Disease
Alzheimer’s disease is a progressive neurodegenerative disorder that is the most common cause of dementia, affecting memory, thinking, and behavior. It typically begins with mild memory loss and gradually worsens, eventually interfering with daily tasks and cognitive function. Characterized by the buildup of abnormal protein deposits—amyloid plaques and tau tangles—in the brain, Alzheimer’s is currently incurable, though research is rapidly evolving. Ongoing scientific studies are exploring its causes, early detection methods, genetic risk factors, and potential treatments, with the goal of better understanding and ultimately halting or reversing the disease.
The human brain’s glymphatic system, instrumental in removing toxins, has been visualized in living people…
Researchers have discovered that methazolamide, a glaucoma drug, can clear tau protein build-up in the…
Scientists have discovered that the brain produces “guardian peptides” that maintain its immune balance, potentially…
Semaglutide may reduce Alzheimer’s risk in type 2 diabetes patients, with research suggesting significant protective…
Researchers have identified a key mechanism in the development of Alzheimer’s disease involving the growth…
Researchers have discovered that traumatic brain injuries (TBI) may increase the risk of developing Alzheimer’s…
Scientists have enhanced a mass spectrometry method to study protein interactions within cells, aiming to…
Researchers discovered that two genetic variants, APOE4 and TREM2 R47H, increase Alzheimer’s disease risk by…
Blood tests for Alzheimer’s diagnosis vary by time of day, with biomarkers being lowest in…
The accumulation of tau protein in the brain interferes with the salience network, a system…
Johns Hopkins researchers reactivated a memory circuit in mice, causing them to seek shelter even…
New research shows astrocytes can remove Alzheimer’s-related amyloid-beta via autophagy, offering a promising new direction…
Researchers have captured the first images of a brain network designed to clear waste, potentially…
Patients tolerated synthetic THC (dronabinol) well, without the adverse effects commonly associated with existing Alzheimer’s…
A new peptide inhibitor, RI-AG03, targets two key areas of the Tau protein in Alzheimer’s…
A study found that phytoene, a carotenoid, extends the lifespan of Caenorhabditis elegans and reduces…
Work could lead to the discovery of new therapeutic targets. For the first time, researchers…